China's coronavirus epidemic that threatens the country and the whole world spooks global markets. Experts fear the deadly infection may cause irreversible damage to the global economy. Against this background, three companies that can make a huge profit from the coronavirus outbreak seem to be tranquil oases

Many experts and market participants are anxious about the rapid spread of the coronavirus and its negative impact on the entire world, including the possibility of a pandemic. Analysts predict that further aggravation of the current situation could push the global market into a recession. However, there are some companies that can benefit from the widespread panic and turn the fight against the epidemic in their favor. Experts believe that these companies will gain even if the situation worsens.

Lakeland Industries, the largest manufacturer of protective suits, may become one of the companies that will benefit from the spread of coronavirus. The corporation produces infection-control gear, including fire-fighting and heat-shielding equipment, disposable protective clothing, hazmat suits, and so on. Since the onset of the outbreak, Lakeland Industries stocks have spiked by 27.6%, hitting a 52-week high of $16.28 per share. In the event of a full-blown epidemic, the demand for the company's products is expected to boom.

Another company that is expected to profit from the epidemic is Alpha Pro Tech, a leading manufacturer of face masks. Alpha Pro Tech supplies the global market with infection-control products and air-filtration face masks. Since the virus emerged, the company's stocks have soared to an impressive 62.8%, hitting a 52-week high of $7.86 per share. Currently, there is rapidly growing demand for face masks, as well as glasses and shoe covers for health care workers in China.

According to experts, the third company that is likely to benefit from the spreading epidemic is Vir Biotechnology. The company specializes in clinical immunology developments, using cutting-edge innovations to treat serious diseases. Over the past few days, the biotech company's stocks have spiked by 30%. At the beginning of 2020, stocks surged by almost 70% to a record high of $27.48 per share. Experts believe that Vir Biotechnology can develop a vaccine against the coronavirus which will enable it to earn on the epidemic.